You are exhausted. You know you need to sleep. You have been telling yourself for two hours that you should go to bed. And yet here you are — scrolling, reading, starting a task that will absolutely not be finished tonight, or simply lying in the dark with a brain that refuses to stop generating thoughts. If you have ADHD, this is not a discipline problem. It is a neurobiology problem with a substantial evidence base behind it.
The numbers
Sleep disturbances affect an estimated 80% of adults with ADHD and up to 82% of children with ADHD.1 These are not minor inconveniences. Research using the National Health and Nutrition Examination Survey (NHANES) found that adults who self-reported ADHD were five times more likely to suffer from insomnia (OR = 5.18) compared to those without ADHD.2 The sleep problems associated with ADHD include prolonged sleep onset latency (difficulty falling asleep), difficulty maintaining sleep, altered total sleep duration, excessive daytime sleepiness, and — most distinctively — delayed sleep phase syndrome.
Delayed sleep phase: the ADHD circadian signature
The most characteristic sleep disturbance in ADHD is not generic insomnia. It is delayed sleep phase syndrome (DSPS) — a circadian rhythm disorder in which the entire sleep-wake cycle is shifted later than the socially conventional timing. You are not unable to sleep; you are unable to sleep at the time the world expects you to sleep.
A 2025 perspective article in Frontiers in Psychiatry synthesised the evidence characterising ADHD as, in part, a circadian rhythm disorder.1 The data are striking: delayed sleep-wake timing occurs in up to 78% of individuals with ADHD. The biological marker for circadian timing — dim-light melatonin onset (DLMO) — is delayed by approximately 45 minutes in children with ADHD and approximately 90 minutes in adults with ADHD compared to non-ADHD controls.1
This means that the internal biological clock that initiates the cascade of physiological changes leading to sleepiness (falling body temperature, rising melatonin, decreasing cortisol) is running later in most people with ADHD. When you tell yourself to go to bed at 10:30pm but your DLMO does not occur until midnight, your body is not biologically ready for sleep at the time you are attempting it. The result is lying awake, experiencing what feels like an inability to "switch off" but is actually a body that has not yet received its neurochemical sleep signal.
This delayed circadian phase also coincides with blunted and delayed cortisol rhythms, reduced pineal gland volume (the gland that produces melatonin), and attenuated peripheral clock-gene rhythms (BMAL1/PER2) — all pointing to a systemic circadian disruption, not simply a behavioural preference for staying up late.1
Why the ADHD brain resists sleep
Beyond circadian delays, several ADHD-specific mechanisms contribute to sleep difficulties:
Hyperarousal at bedtime. The ADHD brain does not downregulate easily. The transition from waking activity to sleep requires a shift from sympathetic (alerting) to parasympathetic (calming) nervous system dominance. In ADHD, this transition is often delayed or incomplete — the brain continues generating thoughts, ideas, worries, and plans long after the body has been placed in bed.
Executive function failures around sleep. Going to bed on time requires prospective memory (remembering to begin the wind-down process), time estimation (accurately judging when to start), impulse control (stopping the current engaging activity), and task initiation (beginning the bedtime routine). These are the exact cognitive functions impaired in ADHD. Sleep hygiene advice that assumes intact executive function — "go to bed at the same time every night," "stop using screens an hour before bed" — fails not because the person does not know these rules but because executing them at the point of performance is precisely their deficit.
Bedtime procrastination. Research on "revenge bedtime procrastination" — staying up late to reclaim personal time after a day of demands — overlaps significantly with ADHD. For many adults with ADHD, the evening is the only time the house is quiet, obligations are paused, and hyperfocus on enjoyable activities can occur without interruption. Sacrificing this for sleep feels like sacrificing the best part of the day.
The stimulant paradox
The relationship between stimulant medication and sleep in ADHD is more complex than the standard warning suggests. The conventional understanding is straightforward: stimulants promote wakefulness, therefore they cause insomnia. This is true for some people, particularly with afternoon or evening dosing.
However, a 2025 longitudinal study published in ScienceDirect, following 149 adults with ADHD over 18 months, found that stimulant use was significantly associated with improved sleep quality and reduced odds of insomnia.3 Non-stimulant medications (atomoxetine) were similarly linked to lower insomnia rates. Antidepressant use, in contrast, significantly increased insomnia risk.
This "stimulant paradox" has a logical explanation: for some people with ADHD, the hyperarousal, racing thoughts, and inability to disengage from activities that prevent sleep are themselves ADHD symptoms. When medication adequately controls these symptoms during the day, the evening transition to sleep becomes easier. The person who is not on medication — or whose medication has worn off entirely by evening — may experience a surge of untreated ADHD symptoms at exactly the time they are trying to wind down.
A 2025 article in PMC explored this concept specifically for methylphenidate, noting that in some individuals it reduces evening restlessness and bedtime procrastination, while in others it contributes to insomnia or reduced total sleep time.4 The variability depends on the interaction between the pharmacokinetic profile (how quickly the drug is metabolised and cleared) and the individual's circadian timing.
Melatonin: what the evidence says
Melatonin is the most studied chronotherapeutic intervention for sleep problems in ADHD. Unlike a sedative, melatonin does not force sleep — it shifts the circadian clock. When taken 3–5 hours before the natural DLMO, exogenous melatonin advances the circadian phase, making the body biologically ready for sleep earlier.
A landmark randomised controlled trial by van Andel and colleagues (2022), published in the Journal of Biological Rhythms, found that melatonin advanced DLMO by 1.5 hours in adults with ADHD and DSPS, and this circadian advance was associated with a 14% reduction in ADHD symptoms.5 Adding bright light therapy in the morning advanced DLMO by 2 hours, though it did not independently improve ADHD symptoms.
However — and this is a critical finding — even though the circadian clock was successfully shifted, participants' actual sleep and wake times did not change. The melatonin made it biologically possible to fall asleep earlier, but years of late-sleep behaviour patterns persisted. Biology was corrected; behaviour was not. This underscores that melatonin alone is insufficient — it needs to be combined with behavioural sleep interventions.
In children with ADHD, the evidence for melatonin is stronger: 19 randomised controlled trials comprising 841 children consistently showed sleep latency improvements of 22–60 minutes without serious adverse effects.6 Long-term follow-up found that 65% continued daily melatonin use, with discontinuation resulting in circadian delay relapse in 92% of cases. Positive improvements in behaviour (71%) and mood (61%) were reported by those who maintained treatment.1
A 2025 UK Delphi consensus study noted that despite the evidence, melatonin is not approved in the UK for most adults with ADHD and is not available over the counter (unlike the US). The consensus group identified a significant unmet need in adult ADHD sleep management.7
Timing matters more than dose. The most common error with melatonin is taking it immediately before the desired bedtime. For circadian phase-shifting, melatonin should be taken 3–5 hours before the target sleep time — often around 7–8pm for someone targeting a midnight sleep onset. Starting at a low dose (0.5–1mg) and adjusting upward is recommended, as the chronobiotic effect does not require high doses.
CBT-I adapted for ADHD
Cognitive Behavioural Therapy for Insomnia (CBT-I) is the gold-standard treatment for chronic insomnia in the general population. Its core components — sleep restriction, stimulus control, cognitive restructuring, and sleep hygiene — are evidence-based and effective. But standard CBT-I assumes executive function capacity that people with ADHD may not have.
A pilot study published in BMC Psychiatry (2019) evaluated a group-delivered CBT-I-based treatment adapted for adult ADHD, involving 19 patients (79% on stimulant medication) with an average of 15.3 years of sleep problems.8 The programme consisted of 10 weekly 90-minute sessions plus scheduled telephone support. Results were significant: insomnia severity improved by 4.5 points on the Insomnia Severity Index at post-treatment (p = .002) and by 6.8 points at 3-month follow-up (p < .0001) — a clinically meaningful improvement.
The adaptations that made this work for ADHD included: external structure and accountability (group format, weekly sessions, phone check-ins), simplified instructions, visual reminders, and explicit problem-solving around the executive function challenges of implementing sleep restriction and stimulus control.
What actually helps: building a sleep system
Understanding the neurobiology is step one. Step two is building an external system that compensates for the specific ways ADHD undermines sleep:
Make the wind-down visible and automatic. Set an alarm for the start of your wind-down routine — not for bedtime, for the beginning of the process. Use a visual checklist for the routine steps. Remove decision-making from the process entirely.
Address the circadian delay. Consider melatonin (timed correctly — hours before bed, not at bedtime), morning bright light exposure (minimum 10,000 lux for 20–30 minutes upon waking), and consistent wake time even on weekends. The wake time is more important than the bedtime for circadian entrainment.
Manage the medication-sleep interaction. If stimulant medication is disrupting sleep, discuss formulation timing with your prescriber. Extended-release formulations with different duration profiles may provide daytime coverage while clearing before sleep onset. If untreated ADHD symptoms are disrupting sleep (hyperarousal, racing thoughts, bedtime procrastination), a short-acting dose in the early evening is sometimes more effective than removing medication entirely.
Track the data. Without consistent sleep tracking, you cannot distinguish between a circadian problem, a medication timing problem, an ADHD behavioural problem, and a comorbid sleep disorder. Record sleep onset time, wake time, perceived sleep quality, medication timing, and any substances (caffeine, alcohol) for at least two weeks. This data is necessary for your clinician to make informed decisions.
Screen for comorbid sleep disorders. ADHD has elevated comorbidity with restless legs syndrome, sleep apnoea, and periodic limb movement disorder. If sleep remains severely disrupted despite addressing circadian timing and ADHD symptom management, a formal sleep study (polysomnography) may be warranted.
The cost of ignoring sleep
Sleep deprivation worsens every symptom of ADHD. Working memory declines. Emotional reactivity increases. Impulse control deteriorates. Time perception becomes even more unreliable. Medication efficacy drops. The relationship between ADHD and sleep is bidirectional: ADHD disrupts sleep, and disrupted sleep worsens ADHD. Breaking this cycle is not a lifestyle upgrade — it is a clinical priority.
